Goserelin

Short Description:


  • Product Name: Goserelin
  • Cas No: 65807-02-5
  • Molecular Formula: C59H84N18O14
  • Molecular Weight: 1269.43 g/mol
  • SEQUECE: Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 acetate salt
  • APPEARANCE: white power
  • PACKAGE: According to customer's requirements
  • Application: Advanced hormone-dependent prostate cancer, Advanced hormone-dependent breast cancer, Endometriosis, Uterine myoma ,Use in reproductive medicine
  • Product Detail

    Product Tags

    Keywords

    • 65807-02-5
    • high purity Goserelin
    • Goserelin acetate

    Quick Details

    • ProName: Goserelin
    • CasNo: 65807-02-5
    • Molecular Formula: C59H84N18O14
    • Appearance: white power
    • Application: Advanced hormone-dependent prostate ca…
    • DeliveryTime: prompt shipment
    • PackAge: According to your needs
    • Port: Shenzhen
    • ProductionCapacity: 2 Kilogram/Month
    • Purity: 98%
    • Storage: 2~8℃,protected from light
    • Transportation: CIF by air
    • LimitNum: 1 Gram

    Superiority

     

    professional goserelin manufacturer in china.
    high quality with gmp grade
    large scale with competitive price
    our products includes: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.

     

    Details

    Molecular Formula:

    C59H84N18O14

    Relative Molecular Mass:

    1269.43 g/mol

    CAS-Number:

    65807-02-5 (net), 145781-92-6 (acetate)

    Long-term Storage:

    -20 ± 5°C

    Synonym:

    (D-Ser(tBu)6,Azagly10)-LHRH

     

    Sequence:

    Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 acetate salt

     

    Fields of Application:

    Advanced hormone-dependent prostate cancer
    Advanced hormone-dependent breast cancer
    Endometriosis
    Uterine myoma
    Use in reproductive medicine

     

    Active Substance:

    Goserelin Acetate is a potent GnRH (LHRH) agonist. After a transient increase, continuous administration of goserelin results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.

    Company Profile:
    company name:Shenzhen JYMed Technology Co.,Ltd.
    Year Established:2009
    Capital: 89.5 Million RMB
    Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate, Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
    We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.  JYM has successfully submitted a lot of ANDA peptide APIs and formulated products with CFDA and have more than fourty patents approved.
    Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of  30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
    With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.

  • Previous:
  • Next:

  • Write your message here and send it to us